{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:30:34Z","timestamp":1792452634031,"version":"4.5.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015391","name":"Sveu\u010dili\u0161te u Splitu","doi-asserted-by":"publisher","award":["AI-IBD (IP-UNIST-32)"],"award-info":[{"award-number":["AI-IBD (IP-UNIST-32)"]}],"id":[{"id":"10.13039\/501100015391","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic relapsing systemic disorder associated with significant extraintestinal manifestations. Emerging evidence indicates that cardiovascular disease represents a clinically important comorbidity in IBD, driven by persistent low-grade inflammation, endothelial dysfunction, and metabolic disturbances.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>The gut microbiota, recognized as a key regulator of host metabolism and immune homeostasis, contributes to cardiovascular physiology through the production of bioactive metabolites. These microbiota-derived metabolites \u2014 including short-chain fatty acids, secondary bile acids, trimethylamine N-oxide, tryptophan-derived indoles, and polyphenol-derived compounds \u2014 can exert cardioprotective or cardiotoxic effects depending on their balance and bioavailability. In IBD, intestinal dysbiosis and impaired epithelial barrier integrity profoundly alter microbial metabolic output, thereby disrupting systemic inflammatory and cardiovascular pathways. This review summarizes current evidence on the role of microbiota-derived metabolites in cardioprotection and examines how IBD-associated dysbiosis disrupts these protective mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Understanding the interplay between gut dysbiosis and cardiovascular risk in IBD may open new therapeutic avenues. Targeting the gut microbiota and its metabolic output represents a promising strategy to mitigate cardiovascular risk in this patient population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-026-01493-6","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:57:18Z","timestamp":1777431438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Microbiota-derived metabolites and cardiovascular implications in Inflammatory Bowel Disease (IBD)"],"prefix":"10.1186","volume":"32","author":[{"given":"Ivna","family":"Oli\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Pavlovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Kumri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roko","family":"\u0160anti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Bratani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u0161ko","family":"Bo\u017ei\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"1493_CR1","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1136\/gutjnl-2020-323071","volume":"70","author":"A Agus","year":"2021","unstructured":"Agus A, Cl\u00e9ment K, Sokol H. Gut Microbiota-Derived Metabolites as Central Regulators in Metabolic Disorders. Gut. 2021;70:1174\u201382. https:\/\/doi.org\/10.1136\/gutjnl-2020-323071.","journal-title":"Gut"},{"issue":"3","key":"1493_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.cgh.2022.08.035","volume":"21","author":"QA Alayo","year":"2023","unstructured":"Alayo QA, Loftus EV Jr, Yarur A, Alvarado D, Ciorba MA, de las Fuentes L, et al. Inflammatory bowel disease is associated with an increased risk of incident acute arterial events: analysis of the United Kingdom Biobank. Clin Gastroenterol Hepatol. 2023;21(3):761-770.e13. https:\/\/doi.org\/10.1016\/j.cgh.2022.08.035. (Epub 2022 Sep 6. PMID: 36075499).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1493_CR3","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.cgh.2018.04.031","volume":"16","author":"S Aniwan","year":"2018","unstructured":"Aniwan S, Pardi DS, Tremaine WJ, et al. Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018;16:1607-1615.e1601.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"1493_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30103","volume":"10","author":"F Arrari","year":"2024","unstructured":"Arrari F, Jabri MA, Ayari A, Dakhli N, Ben Fayala C, Boubaker S, et al. Amino acid HPLC-FLD analysis of spirulina and its protective mechanism against the combination of obesity and colitis in Wistar rats. Heliyon. 2024;10(9):e30103. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30103. (PMID: 38694088; PMCID: PMC11061748).","journal-title":"Heliyon"},{"key":"1493_CR5","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.clnu.2018.01.020","volume":"38","author":"JJ Ashton","year":"2019","unstructured":"Ashton JJ, Gavin J, Beattie RM. Exclusive enteral nutrition in Crohn\u2019s disease: evidence and practicalities. Clin Nutr. 2019;38:80\u20139.","journal-title":"Clin Nutr"},{"issue":"6","key":"1493_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099411","volume":"9","author":"C Bang","year":"2014","unstructured":"Bang C, Weidenbach K, Gutsmann T, Heine H, Schmitz RA. The intestinal archaea Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cells. PLoS ONE. 2014;9(6):e99411.","journal-title":"PLoS ONE"},{"issue":"34","key":"1493_CR7","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034758","volume":"102","author":"Y Banno","year":"2023","unstructured":"Banno Y, Nomura M, Hara R, et al. Trimethylamine N-oxide and risk of inflammatory bowel disease: a Mendelian randomization study. Medicine. 2023;102(34):e34758. https:\/\/doi.org\/10.1097\/MD.0000000000034758.","journal-title":"Medicine"},{"issue":"14","key":"1493_CR8","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/CIRCULATIONAHA.122.060573","volume":"147","author":"TW Benson","year":"2023","unstructured":"Benson TW, Conrad KA, Li XS, Wang Z, Helsley RN, Schugar RC, et al. Gut microbiota-derived Trimethylamine N-Oxide contributes to abdominal aortic aneurysm through inflammatory and apoptotic mechanisms. Circulation. 2023;147(14):1079\u201396. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.060573. (Epub 2023 Apr 3. PMID: 37011073; PMCID: PMC10071415).","journal-title":"Circulation"},{"issue":"5","key":"1493_CR9","first-page":"281","volume":"19","author":"ML Borum","year":"2023","unstructured":"Borum ML. Racial and ethnic disparities in inflammatory bowel disease. Gastroenterol Hepatol (n y). 2023;19(5):281\u20133.","journal-title":"Gastroenterol Hepatol (n y)"},{"key":"1493_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030660","author":"K Borrello","year":"2022","unstructured":"Borrello K, et al. Dietary intake mediates ethnic differences in gut microbial composition. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14030660.","journal-title":"Nutrients"},{"key":"1493_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108867","volume":"214","author":"MA Bringer","year":"2022","unstructured":"Bringer MA, Gabrielle PH, Bron AM, Creuzot-Garcher C, Acar N. The gut microbiota in retinal diseases. Exp Eye Res. 2022;214:108867. https:\/\/doi.org\/10.1016\/j.exer.2021.108867.","journal-title":"Exp Eye Res"},{"issue":"1","key":"1493_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05903-3","volume":"15","author":"MJ Budoff","year":"2025","unstructured":"Budoff MJ, de Oliveira Otto MC, Li XS, Lee Y, Wang M, Lai HTM, et al. Trimethylamine-N-oxide (TMAO) and risk of incident cardiovascular events in the multi ethnic study of atherosclerosis. Sci Rep. 2025;15(1):23362. https:\/\/doi.org\/10.1038\/s41598-025-05903-3. (PMID: 40603925; PMCID: PMC12222875).","journal-title":"Sci Rep"},{"key":"1493_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","volume":"30","author":"J Cai","year":"2022","unstructured":"Cai J, Sun L, Gonzalez FJ. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe. 2022b;30:289\u2013300.","journal-title":"Cell Host Microbe"},{"key":"1493_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1551","volume":"14","author":"Y Cai","year":"2022","unstructured":"Cai Y, Chen L, Zhang S, Zeng L, Zeng G. The role of gut microbiota in infectious diseases. Wires Mech Dis. 2022a;14:e1551. https:\/\/doi.org\/10.1002\/wsbm.1551.","journal-title":"Wires Mech Dis"},{"key":"1493_CR15","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.2337\/db06-1491","volume":"56","author":"PD Cani","year":"2007","unstructured":"Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761\u201372. https:\/\/doi.org\/10.2337\/db06-1491.","journal-title":"Diabetes"},{"key":"1493_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020294","volume":"11","author":"C Campbell","year":"2023","unstructured":"Campbell C, Kandalgaonkar MR, Golonka RM, Yeoh BS, Vijay-Kumar M, Saha P. Crosstalk between gut microbiota and host immunity: impact on inflammation and immunotherapy. Biomedicines. 2023;11:294. https:\/\/doi.org\/10.3390\/biomedicines11020294.","journal-title":"Biomedicines"},{"issue":"12","key":"1493_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126242","volume":"22","author":"M Candelli","year":"2021","unstructured":"Candelli M, Franza L, Pignataro G, Ojetti V, Covino M, Piccioni A, et al. Interaction between lipopolysaccharide and gut microbiota in inflammatory bowel diseases. Int J Mol Sci. 2021;22(12):6242. https:\/\/doi.org\/10.3390\/ijms22126242. (PMID: 34200555; PMCID: PMC8226948).","journal-title":"Int J Mol Sci"},{"issue":"33","key":"1493_CR18","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.1093\/eurheartj\/ehz893","volume":"41","author":"R Carnevale","year":"2020","unstructured":"Carnevale R, Sciarretta S, Valenti V, di Nonno F, Calvieri C, Nocella C, et al. Low-grade endotoxaemia enhances artery thrombus growth via toll-like receptor 4: implication for myocardial infarction. Eur Heart J. 2020;41(33):3156\u201365. https:\/\/doi.org\/10.1093\/eurheartj\/ehz893. (PMID: 31898723).","journal-title":"Eur Heart J"},{"key":"1493_CR19","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/gutjnl-2016-313099","volume":"66","author":"B Chassaing","year":"2017","unstructured":"Chassaing B, Van de Wiele T, De Bodt J, Marzorati M, Gewirtz AT. Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut. 2017;66:1414\u201327.","journal-title":"Gut"},{"key":"1493_CR20","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.amjmed.2022.08.012","volume":"135","author":"B Chen","year":"2022","unstructured":"Chen B, Collen LV, Mowat C, Isaacs KL, Singh S, Kane SV, et al. Inflammatory bowel disease and cardiovascular diseases. Am J Med. 2022;135:1453\u201360. https:\/\/doi.org\/10.1016\/j.amjmed.2022.08.012.","journal-title":"Am J Med"},{"key":"1493_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/ehjqcco\/qcad059","volume":"10","author":"J Chen","year":"2024","unstructured":"Chen J, Sun Y, Fu T, et al. Risk of incident cardiovascular disease among patients with gastrointestinal disorder: a prospective cohort study of 330 751 individuals. Eur Heart J Qual Care Clin Outcomes. 2024;10:357\u201365.","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"1493_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jconrel.2023.09.028","volume":"363","author":"L Chen","year":"2023","unstructured":"Chen L, Zhao R, Kang Z, Cao Z, Liu N, Shen J, et al. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance. J Control Release. 2023;363:43\u201356. https:\/\/doi.org\/10.1016\/j.jconrel.2023.09.028.","journal-title":"J Control Release"},{"issue":"1","key":"1493_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600324","volume":"61","author":"CE Cho","year":"2017","unstructured":"Cho CE, Taesuwan S, Malysheva OV, et al. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: a randomized controlled trial. Mol Nutr Food Res. 2017;61(1):1600324. https:\/\/doi.org\/10.1002\/mnfr.201600324.","journal-title":"Mol Nutr Food Res"},{"key":"1493_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/jpm14020196","volume":"14","author":"AA Cisek","year":"2024","unstructured":"Cisek AA, Szymanska E, Aleksandrzak-Piekarczyk T, Cukrowska B. The role of methanogenic archaea in Inflammatory Bowel Disease\u2014a review. J Pers Med. 2024;14:196. https:\/\/doi.org\/10.3390\/jpm14020196.","journal-title":"J Pers Med"},{"key":"1493_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2023;21:236\u201347.","journal-title":"Nat Rev Microbiol"},{"issue":"7","key":"1493_CR26","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1007\/s00394-021-02491-6","volume":"60","author":"KS Coutinho-Wolino","year":"2021","unstructured":"Coutinho-Wolino KS, de F Cardozo LFM, de Oliveira Leal V, et al. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far? Eur J Nutr. 2021;60(7):3567\u201384. https:\/\/doi.org\/10.1007\/s00394-021-02491-6.","journal-title":"Eur J Nutr"},{"key":"1493_CR27","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.3390\/biomedicines10092144","volume":"10","author":"MC Curia","year":"2022","unstructured":"Curia MC, Pignatelli P, D\u2019Antonio DL, D\u2019Ardes D, Olmastroni E, Scorpiglione L, et al. Oral Porphyromonas gingivalis and Fusobacterium nucleatum Abundance in Subjects in Primary and Secondary Cardiovascular Prevention, with or without Heterozygous Familial Hypercholesterolemia. Biomedicines. 2022;10:2144. https:\/\/doi.org\/10.3390\/biomedicines10092144.","journal-title":"Biomedicines"},{"issue":"2","key":"1493_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/10408398.2020.1733483","volume":"61","author":"TF da Silva","year":"2021","unstructured":"da Silva TF, Casarotti SN, de Oliveira GLV, Penna ALB. The Impact of Probiotics, Prebiotics, and Synbiotics on the Biochemical, Clinical, and Immunological Markers, as Well as on the Gut Microbiota of Obese Hosts. Crit Rev Food Sci Nutr. 2021;61(2):337\u201355. https:\/\/doi.org\/10.1080\/10408398.2020.1733483.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1493_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11154-023-09798-1","volume":"24","author":"A Di Ciaula","year":"2023","unstructured":"Di Ciaula A, Bonfrate L, Khalil M, Garruti G, Portincasa P. Contribution of the microbiome for better phenotyping of people living with obesity. Rev Endocr Metab Disord. 2023;24:839\u201370. https:\/\/doi.org\/10.1007\/s11154-023-09798-1.","journal-title":"Rev Endocr Metab Disord"},{"key":"1493_CR30","doi-asserted-by":"publisher","unstructured":"Doukas PG, Doukas SG, Broder A. Effectiveness and Safety of Fecal Microbiota Transplantation for Ulcerative Colitis Treatment: A Systematic Review and Meta-Analysis. Dig Dis. 2025:1\u201314. https:\/\/doi.org\/10.1159\/000548568. Epub ahead of print. PMID: 41078065.","DOI":"10.1159\/000548568"},{"key":"1493_CR31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.114.009990","volume":"130","author":"A Dregan","year":"2014","unstructured":"Dregan A, Charlton J, Chowienczyk P, et al. Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study. Circulation. 2014;130:837\u201344.","journal-title":"Circulation"},{"key":"1493_CR32","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/apt.17932","volume":"59","author":"C Eriksson","year":"2024","unstructured":"Eriksson C, Sun J, Bryder M, et al. Impact of inflammatory bowel disease on the risk of acute coronary syndrome: a Swedish nationwide cohort study. Aliment Pharmacol Ther. 2024;59:1122\u201333.","journal-title":"Aliment Pharmacol Ther"},{"key":"1493_CR33","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.cmi.2022.08.027","volume":"29","author":"S Federici","year":"2023","unstructured":"Federici S, Kviatcovsky D, Vald\u00e9s-Mas R, Elinav E. Microbiome-phage interactions in inflammatory bowel disease. Clin Microbiol Infect. 2023;29:682\u20138. https:\/\/doi.org\/10.1016\/j.cmi.2022.08.027.","journal-title":"Clin Microbiol Infect"},{"key":"1493_CR34","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1093\/ecco-jcc\/jjad098","volume":"17","author":"R Feng","year":"2023","unstructured":"Feng R, Tian Z, Mao R, Ma R, Luo W, Zhao M, et al. Gut microbiome-generated Phenylacetylglutamine from dietary protein is associated with Crohn\u2019s Disease and exacerbates colitis in mouse model possibly via platelet activation. J Crohns Colitis. 2023;17:1833\u201346. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjad098.","journal-title":"J Crohns Colitis"},{"key":"1493_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/10985549.2024.2345363","volume":"44","author":"H Fu","year":"2024","unstructured":"Fu H, Li D, Shuai W, Kong B, Wang X, Tang Y, et al. Effects of Phenylacetylglutamine on the susceptibility of atrial fibrillation in overpressure-induced HF mice. Mol Cell Biol. 2024;44:149\u201363. https:\/\/doi.org\/10.1080\/10985549.2024.2345363.","journal-title":"Mol Cell Biol"},{"key":"1493_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2025-335610","author":"W Fusco","year":"2025","unstructured":"Fusco W, Adolph T, Cammarota G, Gasbarrini A, Ianiro G, Tilg H. Gut microbiota and atherosclerosis. Gut. 2025. https:\/\/doi.org\/10.1136\/gutjnl-2025-335610.","journal-title":"Gut"},{"key":"1493_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/17562848261424145","volume":"19","author":"J Geng","year":"2026","unstructured":"Geng J, Chen J, Ol\u00e9n O, Halfvarson J, Sundstr\u00f6m J, Yuan S, et al. Association of inflammatory bowel disease with cardiovascular disease, and the mediating role of inflammation: a matched-cohort study. Ther Adv Gastroenterol. 2026;19:17562848261424145. https:\/\/doi.org\/10.1177\/17562848261424145. (PMID: 41757295; PMCID: PMC12932890).","journal-title":"Ther Adv Gastroenterol"},{"key":"1493_CR38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.biopha.2017.11.016","volume":"97","author":"J Geng","year":"2018","unstructured":"Geng J, Yang C, Wang B, Zhang X, Hu T, Gu Y, et al. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway. Biomed Pharmacother. 2018;97:941\u20137. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.016.","journal-title":"Biomed Pharmacother"},{"key":"1493_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.926","volume":"11","author":"M Ghasemi-Dehnoo","year":"2023","unstructured":"Ghasemi-Dehnoo M, Lorigooini Z, Amini-Khoei H, Sabzevary-Ghahfarokhi M, Rafieian-Kopaei M. Quinic acid ameliorates ulcerative colitis in rats, through the inhibition of two TLR4-NF-\u03baB and NF-\u03baB-INOS-NO signaling pathways. Immunol Inflamm Dis. 2023;11:e926. https:\/\/doi.org\/10.1002\/iid3.926.","journal-title":"Immunol Inflamm Dis"},{"key":"1493_CR40","doi-asserted-by":"crossref","unstructured":"Gupta V, et al. Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis. Aliment Pharm Ther. 2016;43:52\u201360.","DOI":"10.1111\/apt.13454"},{"issue":"1","key":"1493_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010531","volume":"23","author":"E Harlacher","year":"2022","unstructured":"Harlacher E, Wollenhaupt J, Baaten CCFMJ, Noels H. Impact of uremic toxins on endothelial dysfunction in chronic kidney disease: a systematic review. Int J Mol Sci. 2022;23(1):531. https:\/\/doi.org\/10.3390\/ijms23010531. (PMID: 35008960; PMCID: PMC8745705.).","journal-title":"Int J Mol Sci"},{"key":"1493_CR42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014681118","volume":"118","author":"F Hao","year":"2021","unstructured":"Hao F, et al. Butyrate enhances CPT1A activity to promote fatty acid oxidation and iTreg differentiation. Proc Natl Acad Sci U S A. 2021;118:e2014681118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1493_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2393270","volume":"16","author":"KE Hays","year":"2024","unstructured":"Hays KE, Pfaffinger JM, Ryznar R. The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease. Gut Microbes. 2024;16:2393270.","journal-title":"Gut Microbes"},{"issue":"1","key":"1493_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-63893-0","volume":"14","author":"S Heinzel","year":"2024","unstructured":"Heinzel S, Jureczek J, Kainulainen V, Nieminen AI, Suenkel U, von Thaler AK, et al. Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals. Sci Rep. 2024;14(1):13513. https:\/\/doi.org\/10.1038\/s41598-024-63893-0. (PMID: 38866914; PMCID: PMC11169261).","journal-title":"Sci Rep"},{"key":"1493_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.783295","author":"Y Houshyar","year":"2021","unstructured":"Houshyar Y, Massimino L, Lamparelli LA, Danese S, Ungaro F. Going beyond bacteria: uncovering the role of archaeome and mycobiome in inflammatory bowel disease. Front Physiol. 2021. https:\/\/doi.org\/10.3389\/fphys.2021.783295.","journal-title":"Front Physiol"},{"key":"1493_CR46","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00394-021-02483-6","volume":"60","author":"L Huang","year":"2021","unstructured":"Huang L, Thonusin C, Chattipakorn N, Chattipakorn SC. Impacts of Gut Microbiota on Gestational Diabetes Mellitus: a Comprehensive Review. Eur J Nutr. 2021;60:2343\u201360. https:\/\/doi.org\/10.1007\/s00394-021-02483-6.","journal-title":"Eur J Nutr"},{"key":"1493_CR47","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","volume":"65","author":"G Ianiro","year":"2016","unstructured":"Ianiro G, Tilg H, Gasbarrini A. Antibiotics as deep modulators of gut microbiota: between good and evil. Gut. 2016;65:1906\u201315.","journal-title":"Gut"},{"issue":"10","key":"1493_CR48","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/nu10101398","volume":"10","author":"MH Janeiro","year":"2018","unstructured":"Janeiro MH, Ram\u00edrez MJ, Milagro FI, et al. Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target. Nutrients. 2018;10(10):1398. https:\/\/doi.org\/10.3390\/nu10101398.","journal-title":"Nutrients"},{"key":"1493_CR49","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.biopha.2017.10.021","volume":"96","author":"S-A Jang","year":"2017","unstructured":"Jang S-A, Park DW, Kwon JE, Song HS, Park B, Jeon H, et al. Quinic acid inhibits vascular inflammation in TNF-\u03b1-stimulated vascular smooth muscle cells. Biomed Pharmacother. 2017;96:563\u201371. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.021.","journal-title":"Biomed Pharmacother"},{"key":"1493_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1634803","volume":"16","author":"E Jian","year":"2025","unstructured":"Jian E, Wang M, Zhang Z, Heng Y, Zhang C, Chen Q, et al. The metabolic endotoxemia and gut microbiota: research trajectories and hot trends across the centuries (1999-2024). Front Microbiol. 2025;16:1634803. https:\/\/doi.org\/10.3389\/fmicb.2025.1634803. (PMID: 40980312; PMCID: PMC12446963).","journal-title":"Front Microbiol"},{"issue":"1","key":"1493_CR51","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1139\/cjm-2012-0305","volume":"59","author":"N Just","year":"2013","unstructured":"Just N, Blais Lecours P, Marcoux\u2010Voiselle M, et al. Archaeal characterization of bioaerosols from cage\u2010housed and floor\u2010housed poultry operations. Can J Microbiol. 2013;59(1):46\u201350. https:\/\/doi.org\/10.1139\/cjm-2012-0305.","journal-title":"Can J Microbiol"},{"issue":"1","key":"1493_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18(1):56\u201366. https:\/\/doi.org\/10.1038\/s41575-020-00360-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1493_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-020-00821-0","volume":"8","author":"N Kazemian","year":"2020","unstructured":"Kazemian N, Mahmoudi M, Halperin F, Wu JC, Pakpour S. Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome. 2020;8:1\u201317. https:\/\/doi.org\/10.1186\/s40168-020-00821-0.","journal-title":"Microbiome"},{"issue":"2","key":"1493_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.chom.2020.05.013","volume":"28","author":"DJ Kenny","year":"2020","unstructured":"Kenny DJ, Plichta DR, Shungin D, Koppel N, Hall AB, Fu B, et al. Cholesterol metabolism by uncultured human gut bacteria influences host cholesterol level. Cell Host Microbe. 2020;28(2):245-57.e6. https:\/\/doi.org\/10.1016\/j.chom.2020.05.013.","journal-title":"Cell Host Microbe"},{"key":"1493_CR55","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.autrev.2019.05.001","volume":"18","author":"H Khan","year":"2019","unstructured":"Khan H, Sureda A, Belwal T, \u00c7etinkaya S, S\u00fcntar \u0130, Tejada S, et al. Polyphenols in the treatment of autoimmune diseases. Autoimmun Rev. 2019;18:647\u201357. https:\/\/doi.org\/10.1016\/j.autrev.2019.05.001.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"1493_CR56","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2522324","volume":"57","author":"SH Kim","year":"2025","unstructured":"Kim SH, Yoon MY, Yoon SS. TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis. Ann Med. 2025;57(1):2522324. https:\/\/doi.org\/10.1080\/07853890.2025.2522324. (Epub 2025 Jun 23. PMID: 40548623).","journal-title":"Ann Med"},{"issue":"1","key":"1493_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5534\/wjmh.190009","volume":"38","author":"YS Kim","year":"2020","unstructured":"Kim YS, et al. Sex differences in gut microbiota. World J Mens Health. 2020;38(1):48\u201360.","journal-title":"World J Mens Health"},{"issue":"7","key":"1493_CR58","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1136\/gutjnl-2017-314015","volume":"67","author":"J Kirchgesner","year":"2018","unstructured":"Kirchgesner J, Beaugerie L, Carrat F, Andersen NN, Jess T, Schwarzinger M, et al. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study. Gut. 2018;67(7):1261\u20138. https:\/\/doi.org\/10.1136\/gutjnl-2017-314015. (Epub 2017 Jun 24. PMID: 28647686).","journal-title":"Gut"},{"issue":"6","key":"1493_CR59","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00824-17","volume":"8","author":"K Koskinen","year":"2017","unstructured":"Koskinen K, Pausan MR, Perras AK, et al. First insights into the diverse human archaeome: specific detection of Archaea in the gastrointestinal tract, lung, and nose and on skin. Mbio. 2017;8(6):e00824-17. https:\/\/doi.org\/10.1128\/mBio.00824-17.","journal-title":"Mbio"},{"issue":"2","key":"1493_CR60","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1194\/jlr.R088989","volume":"60","author":"A Kriaa","year":"2019","unstructured":"Kriaa A, Bourgin M, Potiron A, Mkaouar H, Jablaoui A, G\u00e9rard P, et al. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects. J Lipid Res. 2019;60(2):323\u201332. https:\/\/doi.org\/10.1194\/jlr.R088989.","journal-title":"J Lipid Res"},{"key":"1493_CR61","doi-asserted-by":"publisher","unstructured":"Kochkarian T, Nagy HI, Li Q. Gut-heart axis: cardiac remodeling and heart failure in the context of inflammatory bowel disease and dysbiosis. Am J Physiol Gastrointest Liver Physiol. 2025;329(1):G122-G137. https:\/\/doi.org\/10.1152\/ajpgi.00016.2025. Epub 2025 May 19. PMID: 40387516; PMCID: PMC12207753.","DOI":"10.1152\/ajpgi.00016.2025"},{"issue":"1","key":"1493_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ph19010118","volume":"19","author":"P Krynicka","year":"2026","unstructured":"Krynicka P, Cortegoso Valdivia P, Morawski M, Marlicz W, Skonieczna-\u017bydecka K, Koulaouzidis A. Microbiota-driven strategies for managing IBD-associated risks: from infections to mental health. Pharmaceuticals (Basel). 2026;19(1):118. https:\/\/doi.org\/10.3390\/ph19010118. (PMID: 41599716; PMCID: PMC12845199).","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"1493_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098062","volume":"24","author":"M Kumric","year":"2023","unstructured":"Kumric M, Urlic H, Bozic J, Vilovic M, Ticinovic Kurir T, Glavas D, et al. Emerging therapies for the treatment of atherosclerotic cardiovascular disease: from bench to bedside. Int J Mol Sci. 2023;24(9):8062. https:\/\/doi.org\/10.3390\/ijms24098062. (PMID: 37175766; PMCID: PMC10178593).","journal-title":"Int J Mol Sci"},{"key":"1493_CR64","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/s41467-019-08711-2","volume":"10","author":"M Luu","year":"2019","unstructured":"Luu M, et al. The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat Commun. 2019;10:760.","journal-title":"Nat Commun"},{"key":"1493_CR65","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/MEG.0b013e32835eb916","volume":"25","author":"KM Lee","year":"2013","unstructured":"Lee KM, Paik CN, Chung WC, Yang JM, Choi MG. Breath methane positivity is more common and higher in patients with objectively proven delayed transit constipation. Eur J Gastroenterol Hepatol. 2013;25:726\u201332. https:\/\/doi.org\/10.1097\/MEG.0b013e32835eb916.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"1493_CR66","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.amjmed.2021.02.029","volume":"134","author":"MT Lee","year":"2021","unstructured":"Lee MT, Mahtta D, Chen L, Hussain A, Al Rifai M, Sinh P, et al. Premature atherosclerotic cardiovascular disease risk among patients with inflammatory bowel disease. Am J Med. 2021a;134(8):1047-1051.e2. https:\/\/doi.org\/10.1016\/j.amjmed.2021.02.029. (Epub 2021 Apr 1. PMID: 33812865).","journal-title":"Am J Med"},{"issue":"17","key":"1493_CR67","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020646","volume":"10","author":"Y Lee","year":"2021","unstructured":"Lee Y, Nemet I, Wang Z, Lai HTM, de Oliveira Otto MC, Lemaitre RN, et al. Longitudinal plasma measures of Trimethylamine N-oxide and risk of atherosclerotic cardiovascular disease events in community-based older adults. J Am Heart Assoc. 2021b;10(17):e020646. https:\/\/doi.org\/10.1161\/JAHA.120.020646. (Epub 2021 Aug 16. PMID: 34398665; PMCID: PMC8649305.).","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"1493_CR68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/BF03165754","volume":"62","author":"JL Lequerica","year":"2006","unstructured":"Lequerica JL, O\u2019Connor JE, Such L, Alberola A, Meseguer I, Dolz M, et al. A halocin acting on Na+\/H+ exchanger of haloarchaea as a new type of inhibitor in NHE of mammals. J Physiol Biochem. 2006;62(4):253\u201362. https:\/\/doi.org\/10.1007\/BF03165754. (PMID: 17615951).","journal-title":"J Physiol Biochem"},{"key":"1493_CR69","doi-asserted-by":"publisher","unstructured":"Li Q, Ma Z, Huo J, Zhang X, Wang R, Zhang S, Jiao J, Dong X, Janssen PH, Ungerfeld EM, Greening C, Tan Z, Wang M. Distinct microbial hydrogen and reductant disposal pathways explain interbreed variations in ruminant methane yield. ISME J. 2024;18(1):wrad016. https:\/\/doi.org\/10.1093\/ismejo\/wrad016. PMID: 38365243; PMCID: PMC10811737.","DOI":"10.1093\/ismejo\/wrad016"},{"issue":"13","key":"1493_CR70","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3390\/foods14132267.PMID:40647020;PMCID:PMC12249245","volume":"14","author":"S Li","year":"2025","unstructured":"Li S, Zhang Z, Luo L, Zhang Y, Huang K, Guan X. Millet Quinic Acid Relieves Colitis by Regulating Gut Microbiota and Inhibiting MyD88\/NF-\u03baB Signaling Pathway. Foods. 2025;14(13):2267. https:\/\/doi.org\/10.3390\/foods14132267.PMID:40647020;PMCID:PMC12249245.","journal-title":"Foods"},{"key":"1493_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-024-00207-w","volume":"5","author":"Y Liang","year":"2024","unstructured":"Liang Y, Li Y, Lee C, Yu Z, Chen C, Liang C. Ulcerative colitis: molecular insights and intervention therapy. Mol Biomed. 2024;5:42. https:\/\/doi.org\/10.1186\/s43556-024-00207-w.","journal-title":"Mol Biomed"},{"key":"1493_CR72","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.nutres.2023.02.007","volume":"112","author":"D Lin","year":"2023","unstructured":"Lin D, Medeiros DM. The microbiome as a major function of the gastrointestinal tract and its implication in micronutrient metabolism and chronic diseases. Nutr Res. 2023;112:30\u201345. https:\/\/doi.org\/10.1016\/j.nutres.2023.02.007. (Epub 2023 Mar 4. PMID: 36965327.).","journal-title":"Nutr Res"},{"key":"1493_CR73","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569:655\u201362. https:\/\/doi.org\/10.1038\/s41586-019-1237-9.","journal-title":"Nature"},{"key":"1493_CR74","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1097\/MCG.0b013e31822fecfe","volume":"45","author":"GT Macfarlane","year":"2011","unstructured":"Macfarlane GT, Macfarlane S. Fermentation in the Human Large Intestine: Its Physiologic Consequences and the Potential Contribution of Prebiotics. J Clin Gastroenterol. 2011;45:S120\u20137. https:\/\/doi.org\/10.1097\/MCG.0b013e31822fecfe.","journal-title":"J Clin Gastroenterol"},{"key":"1493_CR75","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ihj.2023.12.003","volume":"76","author":"S Majumder","year":"2024","unstructured":"Majumder S, Kiritkumar MR, Shetty V, Mukherjee S, Narayan P. Cardiovascular diseases and the heart-gut cross talk. Indian Heart J. 2024;76:94\u2013100. https:\/\/doi.org\/10.1016\/j.ihj.2023.12.003.","journal-title":"Indian Heart J"},{"key":"1493_CR76","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41577-024-01049-x","volume":"24","author":"KA Maki","year":"2024","unstructured":"Maki KA, Sack MN, Hall KD. Ultra-processed foods: increasing the risk of inflammation and immune dysregulation? Nat Rev Immunol. 2024;24:453\u20134. https:\/\/doi.org\/10.1038\/s41577-024-01049-x.","journal-title":"Nat Rev Immunol"},{"key":"1493_CR77","unstructured":"Malik TF, Aurelio DM. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2023. Extraintestinal manifestations of inflammatory bowel disease. https:\/\/pubmed.ncbi.nlm.nih.gov\/33760556\/."},{"key":"1493_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082236","volume":"12","author":"S Martin-Pelaez","year":"2020","unstructured":"Martin-Pelaez S, Fito M, Castaner O. Mediterranean Diet effects on Type 2 Diabetes prevention, disease progression, and related mechanisms. a review. Nutrients. 2020;12:2236. https:\/\/doi.org\/10.3390\/nu12082236.","journal-title":"Nutrients"},{"key":"1493_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2024.106621","volume":"245","author":"S Matysik","year":"2025","unstructured":"Matysik S, Elger T, Huss M, Liebisch G, H\u00f6ring M, Loibl J, et al. Unique sterol metabolite shifts in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis. J Steroid Biochem Mol Biol. 2025;245:106621. https:\/\/doi.org\/10.1016\/j.jsbmb.2024.106621. (Epub 2024 Sep 16. PMID: 39293724.).","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1493_CR80","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1080\/19490976.2019.1586038","volume":"10","author":"C Menni","year":"2019","unstructured":"Menni C, Hernandez MM, Vital M, Mohney RP, Spector TD, Valdes AM. Circulating levels of the anti-oxidant Indoleproprionic Acid are associated with higher gut microbiome diversity. Gut Microbes. 2019;10:688\u201395. https:\/\/doi.org\/10.1080\/19490976.2019.1586038.","journal-title":"Gut Microbes"},{"issue":"1","key":"1493_CR81","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-025-01030-1","volume":"28","author":"CB Miller","year":"2026","unstructured":"Miller CB, Bader GA, Kay CL. Fecal microbiota transplantation in 2025: Two steps forward, one step back. Curr Gastroenterol Rep. 2026;28(1):5. https:\/\/doi.org\/10.1007\/s11894-025-01030-1. (PMID: 41530607; PMCID: PMC12799677).","journal-title":"Curr Gastroenterol Rep"},{"issue":"4","key":"1493_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/nu11040923","volume":"11","author":"S Mills","year":"2019","unstructured":"Mills S, Stanton C, Lane JA, Smith GJ, Ross RP. Precision nutrition and the microbiome, Part I: current state of the science. Nutrients. 2019;11(4):923. https:\/\/doi.org\/10.3390\/nu11040923.","journal-title":"Nutrients"},{"key":"1493_CR83","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1038\/s41591-022-01990-1","volume":"28","author":"CJL Murray","year":"2022","unstructured":"Murray CJL. The Global Burden of Disease Study at 30 years. Nat Med. 2022;28:2019\u201326. https:\/\/doi.org\/10.1038\/s41591-022-01990-1.","journal-title":"Nat Med"},{"issue":"5","key":"1493_CR84","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/ATVBAHA","volume":"45","author":"V Nageswaran","year":"2025","unstructured":"Nageswaran V, Carreras A, Reinshagen L, Beck KR, Steinfeldt J, Henricsson M, et al. Gut microbial metabolite Imidazole Propionate impairs endothelial cell function and promotes the development of atherosclerosis. Arterioscler Thromb Vasc Biol. 2025;45(5):823\u201339. https:\/\/doi.org\/10.1161\/ATVBAHA.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"1493_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109087","volume":"24","author":"A Nesci","year":"2023","unstructured":"Nesci A, Carnuccio C, Ruggieri V, D\u2019Alessandro A, Di Giorgio A, Santoro L, et al. Gut microbiota and cardiovascular disease: evidence on the metabolic and inflammatory background of a complex relationship. Int J Mol Sci. 2023;24(10):9087. https:\/\/doi.org\/10.3390\/ijms24109087.","journal-title":"Int J Mol Sci"},{"key":"1493_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","volume":"11","author":"A Nishida","year":"2018","unstructured":"Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11:1\u201310. https:\/\/doi.org\/10.1007\/s12328-017-0813-5.","journal-title":"Clin J Gastroenterol"},{"issue":"1","key":"1493_CR87","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-025-01329-4","volume":"27","author":"O Noble","year":"2025","unstructured":"Noble O, Jeon D, Lewis M, Fan C, Nasir K, Abraham BP. From gut inflammation to cardiovascular conflagration: mapping IBD\u2019s cardiometabolic risks. Curr Atheroscler Rep. 2025;27(1):89. https:\/\/doi.org\/10.1007\/s11883-025-01329-4. (PMID: 40928712).","journal-title":"Curr Atheroscler Rep"},{"key":"1493_CR88","doi-asserted-by":"publisher","DOI":"10.1177\/03913988251415094","author":"A Novokhodko","year":"2026","unstructured":"Novokhodko A, Du N, Hao S, Wang Z, Sadilek M, Shu Z, et al. Albumin dialysis modeling predicts the impact of polysulfone dialyzers and flow rate on cholic acid and indoxyl sulfate removal. Int J Artif Organs. 2026. https:\/\/doi.org\/10.1177\/03913988251415094. (Epub ahead of print. PMID: 41656579.).","journal-title":"Int J Artif Organs"},{"key":"1493_CR89","doi-asserted-by":"crossref","unstructured":"Ormsby, M. J. et al. Inflammation associated ethanolamine facilitates infection by Crohn\u2019s disease-linked adherent-invasive Escherichia coli. EBioMedicine. 2019;43: 325\u2013332.","DOI":"10.1016\/j.ebiom.2019.03.071"},{"issue":"2","key":"1493_CR90","first-page":"40","volume":"20","author":"N Ozmeric","year":"2018","unstructured":"Ozmeric N, Bissada N, da Silva APB. The Association between Inflammatory Bowel Disease and Periodontal Conditions: Is There a Common Bacterial Etiology? J Int Acad Periodontol. 2018;20(2):40\u201351 (PMID: 31522142).","journal-title":"J Int Acad Periodontol"},{"issue":"3","key":"1493_CR91","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s12602-019-09585-y","volume":"12","author":"SA Palaniyandi","year":"2020","unstructured":"Palaniyandi SA, Damodharan K, Suh JW, Yang SH. Probiotic Characterization of Cholesterol-Lowering Lactobacillus fermentum MJM60397. Probiotics Antimicrob Proteins. 2020;12(3):1161\u201372. https:\/\/doi.org\/10.1007\/s12602-019-09585-y. (PMID: 31432401).","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"2","key":"1493_CR92","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/jcag\/gwaa002","volume":"4","author":"JX Pang","year":"2021","unstructured":"Pang JX, Kheirkhahrahimabadi H, Bindra S, et al. Differential effect of genetic burden on disease phenotypes in Crohn\u2019s Disease and ulcerative colitis in a Canadian cohort. J Can Assoc Gastroenterol. 2021;4(2):65\u201372. https:\/\/doi.org\/10.1093\/jcag\/gwaa002.","journal-title":"J Can Assoc Gastroenterol"},{"key":"1493_CR93","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3389\/fimmu.2019.00277","volume":"10","author":"D Parada Venegas","year":"2019","unstructured":"Parada Venegas D, et al. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front Immunol. 2019;10:277.","journal-title":"Front Immunol"},{"key":"1493_CR94","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","volume":"156","author":"S Paramsothy","year":"2019","unstructured":"Paramsothy S, et al. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis. Gastroenterology. 2019;156:1440-1454.e2.","journal-title":"Gastroenterology"},{"issue":"24","key":"1493_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/nu17243945","volume":"17","author":"N Pavlovi\u0107","year":"2025","unstructured":"Pavlovi\u0107 N, Todorovi\u0107 P, Maglica M, Kumri\u0107 M, Bo\u017ei\u0107 J. Nutrient-induced remodeling of the adipose-cardiac axis: Metabolic flexibility, adipokine signaling, and therapeutic implications for cardiometabolic disease. Nutrients. 2025;17(24):3945. https:\/\/doi.org\/10.3390\/nu17243945. (PMID: 41470890; PMCID: PMC12735522).","journal-title":"Nutrients"},{"key":"1493_CR96","doi-asserted-by":"publisher","first-page":"24400","DOI":"10.1021\/acs.jafc.4c04456","volume":"72","author":"K Peng","year":"2024","unstructured":"Peng K, et al. Butyrate inhibits the HDAC8\/NF-\u03baB pathway to enhance Slc26a3 expression and improve the intestinal epithelial barrier to relieve colitis. J Agric Food Chem. 2024;72:24400\u201316.","journal-title":"J Agric Food Chem"},{"key":"1493_CR97","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/ptr.2628","volume":"23","author":"RW Pero","year":"2009","unstructured":"Pero RW, Lund H, Leanderson T. Antioxidant metabolism induced by quinic acid. Increased urinary excretion of tryptophan and nicotinamide. Phytother Res. 2009;23:335\u201346. https:\/\/doi.org\/10.1002\/ptr.2628.","journal-title":"Phytother Res"},{"issue":"2","key":"1493_CR98","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1210\/clinem\/dgad510","volume":"109","author":"BA Peters","year":"2024","unstructured":"Peters BA, et al. Sex hormones, the stool microbiome, and subclinical atherosclerosis in women with and without HIV. J Clin Endocrinol Metab. 2024;109(2):483\u201397.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1493_CR99","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/cmi.12308","volume":"16","author":"C Petersen","year":"2014","unstructured":"Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014;16(7):1024\u201333. https:\/\/doi.org\/10.1111\/cmi.12308.","journal-title":"Cell Microbiol"},{"key":"1493_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15184546","author":"S Piawah","year":"2023","unstructured":"Piawah S, et al. Associations between the gut microbiota, race, and ethnicity of patients with colorectal cancer: a pilot and feasibility study. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15184546.","journal-title":"Cancers (Basel)"},{"key":"1493_CR101","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/ecco-jcc\/jjy207","volume":"13","author":"B Pigneur","year":"2019","unstructured":"Pigneur B, et al. Mucosal healing and bacterial composition in response to enteral nutrition vs steroid-based induction therapy-a randomised prospective clinical trial in children with Crohn\u2019s Disease. J Crohns Colitis. 2019;13:846\u201355.","journal-title":"J Crohns Colitis"},{"key":"1493_CR102","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","volume":"14","author":"TWH Pols","year":"2011","unstructured":"Pols TWH, Nomura M, Harach T, Lo Sasso G, Oosterveer MH, Thomas C, et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab. 2011;14:747\u201357. https:\/\/doi.org\/10.1016\/j.cmet.2011.11.006.","journal-title":"Cell Metab"},{"key":"1493_CR103","first-page":"489","volume":"8","author":"S Prasada","year":"2020","unstructured":"Prasada S, Rivera A, Nishtala A, et al. Differential associations of chronic inflammatory diseases with incident heart failure. Heart Fail. 2020;8:489\u201398.","journal-title":"Heart Fail"},{"key":"1493_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2025.102056","volume":"78","author":"P Puca","year":"2025","unstructured":"Puca P, Coppola G, Parello S, Capobianco I, Colantuono S, Scaldaferri F, et al. Atherosclerotic cardiovascular disease and inflammatory bowel disease: epidemiology, pathogenesis and risk assessment. Best Pract Res Clin Gastroenterol. 2025;78:102056. https:\/\/doi.org\/10.1016\/j.bpg.2025.102056.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"10","key":"1493_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/nu15102236","volume":"15","author":"Z Puljiz","year":"2023","unstructured":"Puljiz Z, Kumric M, Vrdoljak J, Martinovic D, Ticinovic Kurir T, Krnic MO, et al. Obesity, gut microbiota, and metabolome: from pathophysiology to nutritional interventions. Nutrients. 2023;15(10):2236. https:\/\/doi.org\/10.3390\/nu15102236.","journal-title":"Nutrients"},{"key":"1493_CR106","doi-asserted-by":"publisher","unstructured":"Qazi T, Amaratunga T, Barnes EL, Fischer M, Kassam Z, Allegretti JR. The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis. Gut Microbes. 2017;8(6):574\u2013588. https:\/\/doi.org\/10.1080\/19490976.2017.1353848. Epub 2017 Sep 12. PMID: 28723262; PMCID: PMC5730391.","DOI":"10.1080\/19490976.2017.1353848"},{"issue":"1","key":"1493_CR107","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-025-01066-5","volume":"47","author":"AC Quiroga-Centeno","year":"2025","unstructured":"Quiroga-Centeno AC, Atanasova K, Ebert MP, Thomann AK, Reindl W. Emerging microbiome-directed therapies in inflammatory bowel disease: beyond diet modification and FMT. Semin Immunopathol. 2025;47(1):42. https:\/\/doi.org\/10.1007\/s00281-025-01066-5. (PMID: 41288714; PMCID: PMC12647200).","journal-title":"Semin Immunopathol"},{"key":"1493_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107608","author":"MM Rahaman","year":"2025","unstructured":"Rahaman MM, Wangchuk P, Sarker S. A systematic review on the role of gut microbiome in inflammatory bowel disease: spotlight on virome and plant metabolites. Microb Pathog. 2025. https:\/\/doi.org\/10.1016\/j.micpath.2025.107608.","journal-title":"Microb Pathog"},{"key":"1493_CR109","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1139\/cjm-2020-0043","volume":"67","author":"E Rajendiran","year":"2021","unstructured":"Rajendiran E, Ramadass B, Ramprasath V. Understanding connections and roles of gut microbiome in cardiovascular diseases. Can J Microbiol. 2021;67:101\u201311. https:\/\/doi.org\/10.1139\/cjm-2020-0043.","journal-title":"Can J Microbiol"},{"issue":"1","key":"1493_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33018-5","volume":"8","author":"A Ramezani","year":"2018","unstructured":"Ramezani A, Nolin TD, Barrows IR, Serrano MG, Buck GA, Regunathan-Shenk R, et al. Gut colonization with methanogenic archaea lowers plasma Trimethylamine N-oxide concentrations in Apolipoprotein e-\/- mice. Sci Rep. 2018;8(1):14752. https:\/\/doi.org\/10.1038\/s41598-018-33018-5. (PMID: 30283097; PMCID: PMC6170401).","journal-title":"Sci Rep"},{"issue":"1","key":"1493_CR111","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/jn\/134.1.153","volume":"134","author":"M Roller","year":"2004","unstructured":"Roller M, Rechkemmer G, Watzl B. Prebiotic Inulin Enriched with Oligofructose in Combination with the Probiotics Lactobacillus rhamnosus and Bifidobacterium lactis Modulates Intestinal Immune Functions in Rats. J Nutr. 2004;134(1):153\u20136. https:\/\/doi.org\/10.1093\/jn\/134.1.153.","journal-title":"J Nutr"},{"issue":"11","key":"1493_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14111111","volume":"14","author":"DM Ruden","year":"2025","unstructured":"Ruden DM. The human archaeome: commensals, opportunists, or emerging pathogens? Pathogens. 2025;14(11):1111. https:\/\/doi.org\/10.3390\/pathogens14111111. (PMID: 41305349; PMCID: PMC12655376.).","journal-title":"Pathogens"},{"key":"1493_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50855-3","volume":"15","author":"PP Saha","year":"2024","unstructured":"Saha PP, Gogonea V, Sweet W, Mohan ML, Singh KD, Anderson JT, et al. Gut microbe-generated Phenylacetylglutamine is an endogenous allosteric modulator of \u03922-Adrenergic receptors. Nat Commun. 2024;15:6696. https:\/\/doi.org\/10.1038\/s41467-024-50855-3.","journal-title":"Nat Commun"},{"issue":"8","key":"1493_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081864","volume":"13","author":"R \u0160anti\u0107","year":"2025","unstructured":"\u0160anti\u0107 R, Pavlovi\u0107 N, Kumri\u0107 M, Vilovi\u0107 M, Bo\u017ei\u0107 J. Pathophysiological links between inflammatory bowel disease and cardiovascular disease: the role of dysbiosis and emerging biomarkers. Biomedicines. 2025;13(8):1864. https:\/\/doi.org\/10.3390\/biomedicines13081864. (PMID: 40868118; PMCID: PMC12383818).","journal-title":"Biomedicines"},{"key":"1493_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-8-79","volume":"8","author":"PD Scanlan","year":"2008","unstructured":"Scanlan PD, Shanahan F, Marchesi JR. Human methanogen diversity and incidence in healthy and diseased colonic groups using McrA gene analysis. BMC Microbiol. 2008;8:79. https:\/\/doi.org\/10.1186\/1471-2180-8-79.","journal-title":"BMC Microbiol"},{"key":"1493_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1366192","volume":"14","author":"M Scanu","year":"2024","unstructured":"Scanu M, Toto F, Petito V, Masi L, Fidaleo M, Puca P, et al. An integrative multi-omic analysis defines gut microbiota, mycobiota, and metabolic fingerprints in ulcerative colitis patients. Front Cell Infect Microbiol. 2024;14:1366192. https:\/\/doi.org\/10.3389\/fcimb.2024.1366192.","journal-title":"Front Cell Infect Microbiol"},{"key":"1493_CR117","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nutres.2021.03.001","volume":"89","author":"NS Schmidt","year":"2021","unstructured":"Schmidt NS, Lorentz A. Dietary restrictions modulate the gut microbiota: implications for health and disease. Nutr Res. 2021;89:10\u201322.","journal-title":"Nutr Res"},{"key":"1493_CR118","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002767","volume":"5","author":"MM Seldin","year":"2016","unstructured":"Seldin MM, Meng Y, Qi H, Zhu W, Wang Z, Hazen SL, et al. Trimethylamine N-oxide promotes vascular inflammation through signaling of mitogen-activated protein kinase and nuclear factor-\u03baB. J Am Heart Assoc. 2016;5:e002767. https:\/\/doi.org\/10.1161\/JAHA.115.002767.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"1493_CR119","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14715\/cmb\/2024.70.11.16","volume":"70","author":"SS Shoarishoar","year":"2024","unstructured":"Shoarishoar SS, Milani F, Adineh S, Sorouri ZR, Attari SM. Comparison of pregnancy outcomes in amniocentesis recipients with normal and abnormal maternal serum analytes. Cell Mol Biol. 2024;70(11):109\u201314. https:\/\/doi.org\/10.14715\/cmb\/2024.70.11.16.","journal-title":"Cell Mol Biol"},{"issue":"14","key":"1493_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/cells14141124","volume":"14","author":"A Shokravi","year":"2025","unstructured":"Shokravi A, Luo Y, Rabkin SW. Cellular and molecular mechanisms explaining the link between inflammatory bowel disease and heart failure. Cells. 2025;14(14):1124. https:\/\/doi.org\/10.3390\/cells14141124. (PMID: 40710377; PMCID: PMC12293421).","journal-title":"Cells"},{"issue":"5","key":"1493_CR121","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3897\/folmed.66.e132325","volume":"66","author":"N Spasova","year":"2024","unstructured":"Spasova N, Somleva D, Krastev B, et al. Effect of Lactobacillus plantarum Supplementation on trimethylamine-N-oxide Levels in 30 Patients with Atherosclerotic Cardiovascular Disease: a double-blind Randomized Controlled Trial. Folia Med. 2024;66(5):682\u201391. https:\/\/doi.org\/10.3897\/folmed.66.e132325.","journal-title":"Folia Med"},{"issue":"1","key":"1493_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-026-04732-6","volume":"26","author":"SC Sudhakaran","year":"2026","unstructured":"Sudhakaran SC, Wayland MT, Purushotham Y, Minchenberg SB, Bains K, Prabakaran S. Beyond the bowel: novel comorbidity patterns in inflammatory bowel disease from the All of Us Research Program. BMC Gastroenterol. 2026;26(1):193. https:\/\/doi.org\/10.1186\/s12876-026-04732-6. (PMID: 41832425; PMCID: PMC13037037).","journal-title":"BMC Gastroenterol"},{"key":"1493_CR123","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cell.2018.08.047","volume":"174","author":"J Suez","year":"2018","unstructured":"Suez J, et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. 2018;174:1406-1423.e16.","journal-title":"Cell"},{"key":"1493_CR124","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1093\/eurheartj\/ehae338","volume":"45","author":"J Sun","year":"2024","unstructured":"Sun J, Yao J, Ol\u00e9n O, et al. Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. Eur Heart J. 2024;45:2493\u2013504.","journal-title":"Eur Heart J"},{"issue":"10","key":"1493_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004305","volume":"20","author":"J Sun","year":"2023","unstructured":"Sun J, Roelstraete B, Svennberg E, Halfvarson J, Sundstr\u00f6m J, Forss A, et al. Long-term risk of arrhythmias in patients with inflammatory bowel disease: a population-based, sibling-controlled cohort study. PLoS Med. 2023;20(10):e1004305. https:\/\/doi.org\/10.1371\/journal.pmed.1004305. (PMID: 37856566; PMCID: PMC10621936.).","journal-title":"PLoS Med"},{"key":"1493_CR126","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8266793","volume":"2022","author":"XY Tan","year":"2022","unstructured":"Tan XY, Xie YJ, Liu XL, Li XY, Jia B. A systematic review and meta-analysis of randomized controlled trials of fecal microbiota transplantation for the treatment of inflammatory bowel disease. Evid Based Complement Alternat Med. 2022;2022:8266793. https:\/\/doi.org\/10.1155\/2022\/8266793. (PMID: 35795291; PMCID: PMC9251102).","journal-title":"Evid Based Complement Alternat Med"},{"key":"1493_CR127","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ejhf.3111","volume":"26","author":"WHW Tang","year":"2024","unstructured":"Tang WHW, Nemet I, Li XS, Wu Y, Haghikia A, Witkowski M, et al. Prognostic value of gut microbe-generated metabolite Phenylacetylglutamine in patients with heart failure. Eur J Heart Fail. 2024;26:233\u201341. https:\/\/doi.org\/10.1002\/ejhf.3111.","journal-title":"Eur J Heart Fail"},{"key":"1493_CR128","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association. Circulation. 2022;145:e153\u2013639. https:\/\/doi.org\/10.1161\/CIR.0000000000001052.","journal-title":"Circulation"},{"issue":"1","key":"1493_CR129","doi-asserted-by":"publisher","first-page":"36","DOI":"10.34172\/apb.2023.004","volume":"13","author":"H Vaez","year":"2023","unstructured":"Vaez H, Soraya H, Garjani A, Gholikhani T. Toll-Like Receptor 4 (TLR4) and AMPK relevance in cardiovascular disease. Adv Pharm Bull. 2023;13(1):36\u201347. https:\/\/doi.org\/10.34172\/apb.2023.004. (Epub 2021 Oct 10. PMID: 36721803; PMCID: PMC9871286).","journal-title":"Adv Pharm Bull"},{"key":"1493_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2021.100912","volume":"61","author":"F Valeri","year":"2021","unstructured":"Valeri F, Endres K. How biological sex of the host shapes its gut microbiota. Front Neuroendocrinol. 2021;61:100912.","journal-title":"Front Neuroendocrinol"},{"key":"1493_CR131","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1136\/gutjnl-2024-333378","volume":"73","author":"M Van Hul","year":"2024","unstructured":"Van Hul M, Cani PD, Petitfils C, De Vos WM, Tilg H, El-Omar EM. What defines a healthy gut microbiome? Gut. 2024;73:1893\u2013908. https:\/\/doi.org\/10.1136\/gutjnl-2024-333378.","journal-title":"Gut"},{"key":"1493_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051434","volume":"12","author":"A Verdugo-Meza","year":"2020","unstructured":"Verdugo-Meza A, Ye J, Dadlani H, Ghosh S, Gibson DL. Connecting the dots between inflammatory bowel disease and metabolic syndrome: a focus on gut-derived metabolites. Nutrients. 2020;12:1434. https:\/\/doi.org\/10.3390\/nu12051434.","journal-title":"Nutrients"},{"issue":"1","key":"1493_CR133","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","volume":"20","author":"F Violi","year":"2023","unstructured":"Violi F, Cammisotto V, Bartimoccia S, Pignatelli P, Carnevale R, Nocella C. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat Rev Cardiol. 2023;20(1):24\u201337. https:\/\/doi.org\/10.1038\/s41569-022-00737-2. (Epub 2022 Jul 15. PMID: 35840742; PMCID: PMC9284488).","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"1493_CR134","doi-asserted-by":"publisher","DOI":"10.3390\/nu14040757","volume":"14","author":"J Vrdoljak","year":"2022","unstructured":"Vrdoljak J, Kumric M, Vilovic M, Martinovic D, Tomic IJ, Krnic M, et al. Effects of olive oil and its components on intestinal inflammation and Inflammatory Bowel Disease. Nutrients. 2022;14(4):757. https:\/\/doi.org\/10.3390\/nu14040757. (PMID: 35215407; PMCID: PMC8875923).","journal-title":"Nutrients"},{"key":"1493_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114736","volume":"43","author":"W Wang","year":"2024","unstructured":"Wang W, et al. Butyrate and propionate are microbial danger signals that activate the NLRP3 inflammasome in human macrophages upon TLR stimulation. Cell Rep. 2024c;43:114736.","journal-title":"Cell Rep"},{"key":"1493_CR136","doi-asserted-by":"publisher","first-page":"12337","DOI":"10.3390\/ijms252212337","volume":"25","author":"Z Wang","year":"2024","unstructured":"Wang Z, Kaplan RC, Burk RD, Qi Q. The Oral Microbiota, Microbial Metabolites, and Immuno-Inflammatory Mechanisms in Cardiovascular Disease. Int J Mol Sci. 2024b;25:12337. https:\/\/doi.org\/10.3390\/ijms252212337.","journal-title":"Int J Mol Sci"},{"key":"1493_CR137","doi-asserted-by":"publisher","unstructured":"Wang X, He L, Dong Y, Qin X, Zhang H, Wang B, Wang S, Cao H. Mucosa-associated bacteria and metabolites in inflammatory bowel disease: from inside to insight NPJ Biofilms Microbiomes. 2026;1https:\/\/doi.org\/10.1038\/s41522-025-00887-4.","DOI":"10.1038\/s41522-025-00887-4"},{"key":"1493_CR138","doi-asserted-by":"publisher","first-page":"8407","DOI":"10.2147\/JIR.S470376","volume":"17","author":"Z Wang","year":"2024","unstructured":"Wang Z, Li B, Bao L, Chen Y, Yang J, Xu F, et al. Fusobacterium nucleatum Aggravates Intestinal Barrier Impairment and Colitis Through IL-8 Induced Neutrophil Chemotaxis by Activating Epithelial Cells. J Inflamm Res. 2024a;17:8407\u201320. https:\/\/doi.org\/10.2147\/JIR.S470376.","journal-title":"J Inflamm Res"},{"key":"1493_CR139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1591151","volume":"16","author":"S Wang","year":"2025","unstructured":"Wang S, Ni Y, Zhou S, Peng H, Cao Y, Zhu Y, et al. Effects of choline metabolite-trimethylamine N-oxide on immunometabolism in inflammatory bowel disease. Front Immunol. 2025;16:1591151. https:\/\/doi.org\/10.3389\/fimmu.2025.1591151. (PMID: 40746564; PMCID: PMC12310921).","journal-title":"Front Immunol"},{"key":"1493_CR140","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1681\/ASN.2017020222","volume":"29","author":"XX Wang","year":"2018","unstructured":"Wang XX, Wang D, Luo Y, Myakala K, Dobrinskikh E, Rosenberg AZ, et al. FXR\/TGR5 dual agonist prevents progression of nephropathy in diabetes and obesity. J Am Soc Nephrol. 2018;29:118\u201337. https:\/\/doi.org\/10.1681\/ASN.2017020222.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"1493_CR141","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1007\/s10620-015-3797-3","volume":"60","author":"A Wilson","year":"2015","unstructured":"Wilson A, Teft WA, Morse BL, et al. Trimethylamine-N-oxide: a novel biomarker for the identification of inflammatory bowel disease. Dig Dis Sci. 2015;60(12):3620\u201330. https:\/\/doi.org\/10.1007\/s10620-015-3797-3.","journal-title":"Dig Dis Sci"},{"key":"1493_CR142","doi-asserted-by":"publisher","unstructured":"Wu H, Hu T, Hao H, Hill MA, Xu C, Liu Z. Inflammatory bowel disease and cardiovascular diseases: a concise review. Eur Heart J Open. 2021;2(1):oeab029. https:\/\/doi.org\/10.1093\/ehjopen\/oeab029. PMID: 35919661; PMCID: PMC9242064.","DOI":"10.1093\/ehjopen\/oeab029"},{"issue":"6","key":"1493_CR143","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01651-22","volume":"10","author":"Y Wu","year":"2022","unstructured":"Wu Y, Jha R, Li A, Liu H, Zhang Z, Zhang C, et al. Probiotics (Lactobacillus plantarum HNU082) supplementation relieves ulcerative colitis by affecting intestinal barrier functions, immunity-related gene expression, gut microbiota, and metabolic pathways in mice. Microbiol Spectr. 2022;10(6):e0165122. https:\/\/doi.org\/10.1128\/spectrum.01651-22. (Epub 2022 Nov 2. PMID: 36321893; PMCID: PMC9769980).","journal-title":"Microbiol Spectr"},{"issue":"4","key":"1493_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11040245","volume":"11","author":"M Yamamoto","year":"2021","unstructured":"Yamamoto M, Shanmuganathan M, Hart L, Pai N, Britz-McKibbin P. Urinary metabolites enable differential diagnosis and therapeutic monitoring of pediatric inflammatory bowel disease. Metabolites. 2021;11(4):245. https:\/\/doi.org\/10.3390\/metabo11040245. (PMID: 33921143; PMCID: PMC8071482).","journal-title":"Metabolites"},{"key":"1493_CR145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.903526","volume":"13","author":"X Ye","year":"2022","unstructured":"Ye X, Li H, Anjum K, Zhong X, Miao S, Zheng G, et al. Dual role of Indoles derived from intestinal microbiota on human health. Front Immunol. 2022;13:903526. https:\/\/doi.org\/10.3389\/fimmu.2022.903526.","journal-title":"Front Immunol"},{"issue":"1","key":"1493_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10010108","volume":"10","author":"JY Yoo","year":"2022","unstructured":"Yoo JY, Sniffen S, McGill Percy KC, et al. Gut dysbiosis and immune system in atherosclerotic cardiovascular disease (ACVD). Microorganisms. 2022;10(1):108. https:\/\/doi.org\/10.3390\/microorganisms10010108.","journal-title":"Microorganisms"},{"key":"1493_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1382332","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. The impact of antibiotic exposure on antibiotic resistance gene dynamics in the gut microbiota of inflammatory bowel disease patients. Front Microbiol. 2024;15:1382332.","journal-title":"Front Microbiol"},{"key":"1493_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156561","volume":"140","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, et al. Polysaccharide from Pyrus pashia Buch ameliorates DSS-induced colitis in mice via MAPKP38\/NF-\u03baB P65 and SCFAs\/ERK\/MSK signaling pathways. Phytomedicine. 2025a;140:156561.","journal-title":"Phytomedicine"},{"key":"1493_CR149","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbrc.2022.03.004","volume":"603","author":"H Zhang","year":"2022","unstructured":"Zhang H, He F, Zhou L, Shi M, Li F, Jia H. Activation of TLR4 induces inflammatory muscle injury via mTOR and NF-\u03baB pathways in experimental autoimmune myositis mice. Biochem Biophys Res Commun. 2022;603:29\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2022.03.004.","journal-title":"Biochem Biophys Res Commun"},{"key":"1493_CR150","doi-asserted-by":"publisher","DOI":"10.1039\/d5fo03078a","author":"L Zhang","year":"2025","unstructured":"Zhang L, Song Y, Chen Y, Li Q, Zhang M. Arabinoxylan and Glycolysis Inhibitors Alleviate Trimethylamine Accumulation and Gut Barrier Impairment by Inhibiting the PERK Pathway. Food Funct. 2025b. https:\/\/doi.org\/10.1039\/d5fo03078a.","journal-title":"Food Funct"},{"key":"1493_CR151","doi-asserted-by":"publisher","first-page":"261","DOI":"10.14336\/AD.2022.0817","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zhou J, Wu W, Zhu Y, Liu X. The role of bile acids in cardiovascular diseases: from mechanisms to clinical implications. Aging Dis. 2023;14:261\u201382. https:\/\/doi.org\/10.14336\/AD.2022.0817.","journal-title":"Aging Dis"},{"key":"1493_CR152","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","volume":"33","author":"X Zheng","year":"2021","unstructured":"Zheng X, et al. Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. Cell Metab. 2021;33:791-803.e7.","journal-title":"Cell Metab"},{"key":"1493_CR153","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/ibd\/izy182","volume":"24","author":"L Zhou","year":"2018","unstructured":"Zhou L, et al. Faecalibacterium prausnitzii produces butyrate to maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm Bowel Dis. 2018;24:1926\u201340.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01493-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:57:10Z","timestamp":1781485030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01493-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01493-6","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}